Kala Pharmaceuticals, Inc. (KALA)
NASDAQ: KALA · IEX Real-Time Price · USD
6.68
+0.34 (5.45%)
Apr 23, 2024, 11:54 AM EDT - Market open
Kala Pharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for KALA stock have an average target of 18, with a low estimate of 15 and a high estimate of 21. The average target predicts an increase of 169.66% from the current stock price of 6.68.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for KALA stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $22 → $21 | Strong Buy | Maintains | $22 → $21 | +214.61% | Apr 2, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $15 | Buy | Reiterates | $15 | +124.72% | Apr 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $24 → $22 | Strong Buy | Maintains | $24 → $22 | +229.59% | Nov 17, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $24 | Strong Buy | Reiterates | $24 | +259.55% | Aug 11, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 → $24 | Strong Buy | Reiterates | $22 → $24 | +259.55% | May 10, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-10.37
from -17.35
EPS Next Year
-11.73
from -10.37
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 26.3M | n/a | 96.4M |
| Avg | n/a | n/a | 25.5M | n/a | 93.7M |
| Low | n/a | n/a | 24.5M | n/a | 90.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 |
|---|---|---|
| High | -9.45 | -12.07 |
| Avg | -10.37 | -11.73 |
| Low | -11.11 | -11.27 |
EPS Growth
| EPS Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.